Bone Morphogenetic Protein Market 2027 By Type, Application, End User and Geography | The Insight Partners

Bone Morphogenetic Protein Market to 2027 - Global Analysis and Forecasts By Type (Recombinant Human Bone Morphogenetic Protein (rhBMP) - 2, Recombinant Human Bone Morphogenetic Protein (rhBMP) -7, Bone morphogenetic protein 4); Application (Spinal Fusion, Trauma, Reconstructive Surgery, Oral-maxillofacial); End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Academic Research, Others) and Geography

Report Code: TIPRE00006919 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Bone morphogenetic proteins (BMPs) are growth factors which belongs to the transforming growth factor beta (TGF-?) superfamily. Several studies have reported that Bone Morphogenetic Protein 2 that belongs to TGF-? superfamily of cytokines inhibits the proliferation of human breast cancer cells. It also plays an important role in bone & cartilage formation and skeletal development during embryogenesis.

MARKET DYNAMICS

The bone morphogenetic protein market is anticipated to grow in the forecast, owing to the factors such as benefits offered by bone morphogenetic proteins than traditional bone grafting procedures, increasing applications of bone morphogenetic proteins, and growing number bone and spinal injuries. Furthermore, growing geriatric population and shift towards sedentary lifestyle leading to bad postures

MARKET SCOPE

The "Global Bone Morphogenetic Proteins Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of bone morphogenetic protein market with detailed market segmentation by type, application, end user and geography. The global bone morphogenetic protein market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Bone morphogenetic protein market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Bone morphogenetic protein market is segmented on the basis of type, application, and end user. Based on type the market is segmented into recombinant human bone morphogenetic protein (rhBMP) - 2, recombinant human bone morphogenetic protein (rhBMP) -7, bone morphogenetic protein 4. Based on application the market is segmented into spinal fusion, trauma, reconstructive surgery, and oral-maxillofacial. Based on end user the market is segmented into hospitals, specialty clinics, ambulatory surgery centers, academic research, and others.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Bone morphogenetic protein market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Bone morphogenetic protein market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Bone morphogenetic protein market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Bone morphogenetic protein market in these regions.

MARKET PLAYERS


The reports cover key developments in the bone morphogenetic protein market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Bone morphogenetic protein market are anticipated to lucrative growth opportunities in the future with the rising demand for Bone morphogenetic protein market in the global market. Below mentioned is the list of few companies engaged in the Bone morphogenetic protein market.

The report also includes the profiles of bone morphogenetic protein market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  DePuy Synthes
  •  Ember therapeutics Inc.
  •  Integra Lifesciences Holdings Corporation
  •  Medtronic PLC
  •  R and D Systems
  •  Merck KGaA
  •  Smith and Nephew, Inc.
  •  Stryker Corporation
  •  Thermo Fischer Scientific
  •  Zimmer Biomet Holdings, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bone Morphogenetic Protein Market - By Type
1.3.2 Bone Morphogenetic Protein Market - By Application
1.3.3 Bone Morphogenetic Protein Market - By End User
1.3.4 Bone Morphogenetic Protein Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. BONE MORPHOGENETIC PROTEIN MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. BONE MORPHOGENETIC PROTEIN MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BONE MORPHOGENETIC PROTEIN MARKET - GLOBAL MARKET ANALYSIS

6.1. BONE MORPHOGENETIC PROTEIN - GLOBAL MARKET OVERVIEW
6.2. BONE MORPHOGENETIC PROTEIN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. BONE MORPHOGENETIC PROTEIN MARKET - REVENUE AND FORECASTS TO 2027 - TYPE

7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN (RHBMP) - 2
7.3.1. Overview
7.3.2. Recombinant Human Bone Morphogenetic Protein (rhBMP) - 2 Market Forecast and Analysis
7.4. RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN (RHBMP) -7
7.4.1. Overview
7.4.2. Recombinant Human Bone Morphogenetic Protein (rhBMP) -7 Market Forecast and Analysis
7.5. BONE MORPHOGENETIC PROTEIN 4
7.5.1. Overview
7.5.2. Bone morphogenetic protein 4 Market Forecast and Analysis

8. BONE MORPHOGENETIC PROTEIN MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION

8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. SPINAL FUSION
8.3.1. Overview
8.3.2. Spinal Fusion Market Forecast and Analysis
8.4. TRAUMA
8.4.1. Overview
8.4.2. Trauma Market Forecast and Analysis
8.5. RECONSTRUCTIVE SURGERY
8.5.1. Overview
8.5.2. Reconstructive Surgery Market Forecast and Analysis
8.6. ORAL-MAXILLOFACIAL
8.6.1. Overview
8.6.2. Oral-maxillofacial Market Forecast and Analysis

9. BONE MORPHOGENETIC PROTEIN MARKET - REVENUE AND FORECASTS TO 2027 - END USER

9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. SPECIALTY CLINICS
9.4.1. Overview
9.4.2. Specialty Clinics Market Forecast and Analysis
9.5. AMBULATORY SURGERY CENTERS
9.5.1. Overview
9.5.2. Ambulatory Surgery Centers Market Forecast and Analysis
9.6. ACADEMIC RESEARCH
9.6.1. Overview
9.6.2. Academic Research Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis

10. BONE MORPHOGENETIC PROTEIN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
10.1.1 North America Bone Morphogenetic Protein Market Overview
10.1.2 North America Bone Morphogenetic Protein Market Forecasts and Analysis
10.1.3 North America Bone Morphogenetic Protein Market Forecasts and Analysis - By Type
10.1.4 North America Bone Morphogenetic Protein Market Forecasts and Analysis - By Application
10.1.5 North America Bone Morphogenetic Protein Market Forecasts and Analysis - By End User
10.1.6 North America Bone Morphogenetic Protein Market Forecasts and Analysis - By Countries
10.1.6.1 United States Bone Morphogenetic Protein Market
10.1.6.1.1 United States Bone Morphogenetic Protein Market by Type
10.1.6.1.2 United States Bone Morphogenetic Protein Market by Application
10.1.6.1.3 United States Bone Morphogenetic Protein Market by End User
10.1.6.2 Canada Bone Morphogenetic Protein Market
10.1.6.2.1 Canada Bone Morphogenetic Protein Market by Type
10.1.6.2.2 Canada Bone Morphogenetic Protein Market by Application
10.1.6.2.3 Canada Bone Morphogenetic Protein Market by End User
10.1.6.3 Mexico Bone Morphogenetic Protein Market
10.1.6.3.1 Mexico Bone Morphogenetic Protein Market by Type
10.1.6.3.2 Mexico Bone Morphogenetic Protein Market by Application
10.1.6.3.3 Mexico Bone Morphogenetic Protein Market by End User
10.2. EUROPE
10.2.1 Europe Bone Morphogenetic Protein Market Overview
10.2.2 Europe Bone Morphogenetic Protein Market Forecasts and Analysis
10.2.3 Europe Bone Morphogenetic Protein Market Forecasts and Analysis - By Type
10.2.4 Europe Bone Morphogenetic Protein Market Forecasts and Analysis - By Application
10.2.5 Europe Bone Morphogenetic Protein Market Forecasts and Analysis - By End User
10.2.6 Europe Bone Morphogenetic Protein Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Bone Morphogenetic Protein Market
10.2.6.1.1 Germany Bone Morphogenetic Protein Market by Type
10.2.6.1.2 Germany Bone Morphogenetic Protein Market by Application
10.2.6.1.3 Germany Bone Morphogenetic Protein Market by End User
10.2.6.2 France Bone Morphogenetic Protein Market
10.2.6.2.1 France Bone Morphogenetic Protein Market by Type
10.2.6.2.2 France Bone Morphogenetic Protein Market by Application
10.2.6.2.3 France Bone Morphogenetic Protein Market by End User
10.2.6.3 Italy Bone Morphogenetic Protein Market
10.2.6.3.1 Italy Bone Morphogenetic Protein Market by Type
10.2.6.3.2 Italy Bone Morphogenetic Protein Market by Application
10.2.6.3.3 Italy Bone Morphogenetic Protein Market by End User
10.2.6.4 Spain Bone Morphogenetic Protein Market
10.2.6.4.1 Spain Bone Morphogenetic Protein Market by Type
10.2.6.4.2 Spain Bone Morphogenetic Protein Market by Application
10.2.6.4.3 Spain Bone Morphogenetic Protein Market by End User
10.2.6.5 United Kingdom Bone Morphogenetic Protein Market
10.2.6.5.1 United Kingdom Bone Morphogenetic Protein Market by Type
10.2.6.5.2 United Kingdom Bone Morphogenetic Protein Market by Application
10.2.6.5.3 United Kingdom Bone Morphogenetic Protein Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Bone Morphogenetic Protein Market Overview
10.3.2 Asia-Pacific Bone Morphogenetic Protein Market Forecasts and Analysis
10.3.3 Asia-Pacific Bone Morphogenetic Protein Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Bone Morphogenetic Protein Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Bone Morphogenetic Protein Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Bone Morphogenetic Protein Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Bone Morphogenetic Protein Market
10.3.6.1.1 Australia Bone Morphogenetic Protein Market by Type
10.3.6.1.2 Australia Bone Morphogenetic Protein Market by Application
10.3.6.1.3 Australia Bone Morphogenetic Protein Market by End User
10.3.6.2 China Bone Morphogenetic Protein Market
10.3.6.2.1 China Bone Morphogenetic Protein Market by Type
10.3.6.2.2 China Bone Morphogenetic Protein Market by Application
10.3.6.2.3 China Bone Morphogenetic Protein Market by End User
10.3.6.3 India Bone Morphogenetic Protein Market
10.3.6.3.1 India Bone Morphogenetic Protein Market by Type
10.3.6.3.2 India Bone Morphogenetic Protein Market by Application
10.3.6.3.3 India Bone Morphogenetic Protein Market by End User
10.3.6.4 Japan Bone Morphogenetic Protein Market
10.3.6.4.1 Japan Bone Morphogenetic Protein Market by Type
10.3.6.4.2 Japan Bone Morphogenetic Protein Market by Application
10.3.6.4.3 Japan Bone Morphogenetic Protein Market by End User
10.3.6.5 South Korea Bone Morphogenetic Protein Market
10.3.6.5.1 South Korea Bone Morphogenetic Protein Market by Type
10.3.6.5.2 South Korea Bone Morphogenetic Protein Market by Application
10.3.6.5.3 South Korea Bone Morphogenetic Protein Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Bone Morphogenetic Protein Market Overview
10.4.2 Middle East and Africa Bone Morphogenetic Protein Market Forecasts and Analysis
10.4.3 Middle East and Africa Bone Morphogenetic Protein Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Bone Morphogenetic Protein Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Bone Morphogenetic Protein Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Bone Morphogenetic Protein Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Bone Morphogenetic Protein Market
10.4.6.1.1 South Africa Bone Morphogenetic Protein Market by Type
10.4.6.1.2 South Africa Bone Morphogenetic Protein Market by Application
10.4.6.1.3 South Africa Bone Morphogenetic Protein Market by End User
10.4.6.2 Saudi Arabia Bone Morphogenetic Protein Market
10.4.6.2.1 Saudi Arabia Bone Morphogenetic Protein Market by Type
10.4.6.2.2 Saudi Arabia Bone Morphogenetic Protein Market by Application
10.4.6.2.3 Saudi Arabia Bone Morphogenetic Protein Market by End User
10.4.6.3 U.A.E Bone Morphogenetic Protein Market
10.4.6.3.1 U.A.E Bone Morphogenetic Protein Market by Type
10.4.6.3.2 U.A.E Bone Morphogenetic Protein Market by Application
10.4.6.3.3 U.A.E Bone Morphogenetic Protein Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Bone Morphogenetic Protein Market Overview
10.5.2 South and Central America Bone Morphogenetic Protein Market Forecasts and Analysis
10.5.3 South and Central America Bone Morphogenetic Protein Market Forecasts and Analysis - By Type
10.5.4 South and Central America Bone Morphogenetic Protein Market Forecasts and Analysis - By Application
10.5.5 South and Central America Bone Morphogenetic Protein Market Forecasts and Analysis - By End User
10.5.6 South and Central America Bone Morphogenetic Protein Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Bone Morphogenetic Protein Market
10.5.6.1.1 Brazil Bone Morphogenetic Protein Market by Type
10.5.6.1.2 Brazil Bone Morphogenetic Protein Market by Application
10.5.6.1.3 Brazil Bone Morphogenetic Protein Market by End User
10.5.6.2 Argentina Bone Morphogenetic Protein Market
10.5.6.2.1 Argentina Bone Morphogenetic Protein Market by Type
10.5.6.2.2 Argentina Bone Morphogenetic Protein Market by Application
10.5.6.2.3 Argentina Bone Morphogenetic Protein Market by End User

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. BONE MORPHOGENETIC PROTEIN MARKET, KEY COMPANY PROFILES

12.1. MEDTRONIC INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MERCK KGAA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. STRYKER CORPORATION
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. THERMO FISCHER SCIENTIFIC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DEPUY SYNTHES
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. EMBER THERAPEUTICS INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. RANDD SYSTEMS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SMITH AND NEPHEW, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ZIMMER BIOMET HOLDINGS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. DePuy Synthes
2. Ember therapeutics Inc.
3. Integra Lifesciences Holdings Corporation
4. Medtronic PLC
5. RandD Systems
6. Merck KGaA
7. Smith and Nephew, Inc.
8. Stryker Corporation
9. Thermo Fischer Scientific
10. Zimmer Biomet Holdings, Inc.